Antiangiogenic Agents: Studies on Fumagillin and Curcumin Analogs
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
357-373
Author(s):
M. S. Furness, T. P. Robinson, T. Ehlers, R. B. Hubbard IV, J. L. Arbiser, D. J. Goldsmith and J. P. Bowena
The Design of Cationic Lipids for Gene Delivery
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
375-394
Author(s):
B. Martin, M. Sainlos, A. Aissaoui, N. Oudrhiri, M. Hauchecorne, J.- P. Vigneron, J.- M. Lehn and P. Lehn
Thalidomide as an Immunotherapeutic Agent: The Effects on Neutrophil- Mediated Inflammation
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
395-401
Author(s):
Kozo Yasui, Norimoto Kobayashi, Takashi Yamazaki and Kazunaga Agematsu
Neurotransmitters and Chemokines Regulate Tumor Cell Migration: Potential for a New Pharmacological Approach to Inhibit Invasion and Metastasis Development
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
403-411
Author(s):
Frank Entschladen, Theodore L. Drell IV, Kerstin Lang, Jan Joseph and Kurt S. Zaenker
Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors
Journal:
Current Genomics
Volume:
6
Page:
13-37
Author(s):
E. J. Kremer
Subject Index to Volume 5
Journal:
Current Genomics
Volume:
6
Page:
65-74
Author(s):
Bentham Science Publishers
Small Interfering RNAs and Antisense Oligonucleotides for Treatment of Neurological Diseases
Journal:
Current Drug Targets
Volume:
6
Page:
21-29
Author(s):
A. Forte, M. Cipollaro, A. Cascino and U. Galderisi
Subject Index to Volume 5
Journal:
Current Drug Targets
Volume:
6
Page:
131-142
Author(s):
Bentham Science Publishers
The Transcriptome in Blood: Challenges and Solutions for Robust Expression Profiling
Journal:
Current Molecular Medicine
Volume:
5
Page:
3-10
Author(s):
Hongtao Fan and Priti S. Hegde
Development of Oncology Drug Response Markers Using Transcription Profiling
Journal:
Current Molecular Medicine
Volume:
5
Page:
103-110
Author(s):
Nicholas C. Dracopoli